Showing results (1571-1580 of 19,551) with videos related to

Sort By:
Pageof 1,956
BMC Cancer|May 3, 2020
Design of a randomized controlled trial of a partnership-based, needs-tailored self-management support intervention for post-treatment breast cancer survivorsSoo Hyun Kim, Yu Hyeon Choe, Ah Reum Han, et al.
BMC Cancer|May 16, 2020
Acquired resistance to DZNep-mediated apoptosis is associated with copy number gains of AHCY in a B-cell lymphoma modelChidimma Agatha Akpa, Karsten Kleo, Elisabeth Oker, et al.
BMC Cancer|May 21, 2020
Sex-specific impact of patterns of imageable tumor growth on survival of primary glioblastoma patientsPaula Whitmire, Cassandra R Rickertsen, Andrea Hawkins-Daarud, et al.
BMC Cancer|May 21, 2020
Comparison of hybrid clones derived from human breast epithelial cells and three different cancer cell lines regarding in vitro cancer stem/ initiating cell propertiesSera Selina Fahlbusch, Silvia Keil, Jörg T Epplen, et al.
BMC Cancer|May 13, 2020
Knowledge-based analyses reveal new candidate genes associated with risk of hepatitis B virus related hepatocellular carcinomaDeke Jiang, Jiaen Deng, Changzheng Dong, et al.
BMC Cancer|June 17, 2015
microRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathwayPengfei Qiao, Guodong Li, Wen Bi, et al.
BMC Cancer|June 19, 2015
Gene expression profiling leads to discovery of correlation of matrix metalloproteinase 11 and heparanase 2 in breast cancer progressionJunjie Fu, Ravil Khaybullin, Yanping Zhang, et al.
BMC Cancer|June 5, 2015
TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patientsLoay Kassem, Mathieu Deygas, Laurent Fattet, et al.
BMC Cancer|June 9, 2015
Categorical versus continuous circulating tumor cell enumeration as early surrogate marker for therapy response and prognosis during docetaxel therapy in metastatic prostate cancer patientsMark Thalgott, Brigitte Rack, Matthias Eiber, et al.
BMC Cancer|June 11, 2015
Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinomaRoman Kloeckner, Arndt Weinmann, Friederike Prinz, et al.
Pageof 1,956